πŸ‡ΊπŸ‡Έ FDA
Patent

US 10342867

Adjuvants

granted A61KA61K2039/55566A61K2039/55572

Quick answer

US patent 10342867 (Adjuvants) held by LITEVAX B.V. expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
LITEVAX B.V.
Grant date
Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K2039/55566, A61K2039/55572, A61K39/145, A61K39/39